systemic lupus erythematosusautoimmune diseasehematologic malignanciesimmune rejectiondaratumumabisatuximabAAALAC-approved facilityMezagitamabanti-CD38 monoclonal antibodies
…):2105–2114. PMID: 29296857McDonnell SRP, et al. Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an aut…